The effects of baicalin on blood lipid metabolism and immune function in rats with gestational diabetes mellitus based on RhoA/ROCK pathway.
- Author:
Yao LU
1
;
Lin SHI
1
;
Le WANG
2
;
Xiaoli LUAN
3
Author Information
1. Department of Obstetrics, Affiliated Qingdao Haici Hospital of Qingdao University(Qingdao Traditional Chinese Medicine Hospital), Qingdao 266000, China.
2. Department of Obstetrics and Gynecology, Affiliated Qingdao Haici Hospital of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266000, China.
3. Department of Obstetrics, Affiliated Qingdao Haici Hospital of Qingdao University(Qingdao Traditional Chinese Medicine Hospital), Qingdao 266000, China. *Corresponding author, E-mail: 573617185@qq.com.
- Publication Type:Journal Article
- MeSH:
Animals;
Female;
Diabetes, Gestational/metabolism*;
Pregnancy;
rho-Associated Kinases/genetics*;
Flavonoids/pharmacology*;
Rats;
rhoA GTP-Binding Protein/genetics*;
Lipid Metabolism/drug effects*;
Male;
Signal Transduction/drug effects*;
Rats, Sprague-Dawley;
Blood Glucose/metabolism*;
Lipids/blood*;
Tumor Necrosis Factor-alpha/blood*;
rho GTP-Binding Proteins
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(11):992-999
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect and mechanism of baicalin on blood lipid metabolism and immune function in rats with gestational diabetes mellitus (GDM). Methods Female rats fed with high-fat and high-sugar diet and male rats fed with ordinary diet were caged together to prepare pregnant rats, and the GDM rat model was established by intraperitoneal injection of streptozotocin (35 mg/kg). GDM rats were randomly divided into a model group, a fasudil (FA) (RhoA/RocK inhibitor) group (10 mg/kg), low-dose (100 mg/kg) and high-dose (200 mg/kg) baicalin groups, and a high-dose baicalin combined with LPA (RhoA/RocK activator) group (200 mg/kg baicalin+1 mg/kg LPA ), with 12 rats in each group. Another 12 pregnant rats fed with high-fat and high-sugar diet were selected as the control group. After 2 weeks of corresponding drug intervention in each group, the level of fasting blood glucose (FBG) was detected by blood glucose meter. The level of fasting insulin (FINS) in serum was detected by ELISA, and the insulin resistance index (HOMA-IR) was calculated. The levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) in serum, and the levels of immunomodulator tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and IL-10 in peripheral blood were detected by the kit. The histopathological changes of liver were observed by HE staining. The proportion of T lymphocyte subsets in peripheral blood was detected by flow cytometry. The mRNA and protein expressions of Ras homolog gene family member A (RhoA), Rho associated coiled-coil forming protein kinase 1 (ROCK1), and ROCK2 in liver tissue were detected by real-time quantitative PCR and Western blot. Results Compared with the control group, the levels of FBG, FINS, HOMA-IR, ALT, AST, TG, TC, and LDL-C in serum, the levels of TNF-α, IL-6, the percentage of CD8+T cell in peripheral blood, and the mRNA and protein expression of RhoA, ROCK1, and ROCK2 in liver tissue in the model group were higher; the level of HDL-C in serum, the percentage of IL-10 levels, CD3+T cells, CD4+T cell, and CD4+T/CD8+T ratio in peripheral blood were lower. Compared with the model group, the levels of FBG, FINS, HOMA-IR, ALT, AST, TG, TC, and LDL-C in serum, the levels of TNF-α, IL-6, the percentage of CD8+T cell in peripheral blood, and the mRNA and protein expression of RhoA, ROCK1, and ROCK2 in liver tissue in the the FA group and low-dose and high-dose baicalin groups were lower; the level of HDL-C in serum, IL-10 level, the percentage of CD3+T cells, CD4+T cell, and CD4+T/CD8+T ratio in peripheral blood were higher. LPA could obviously weaken the improvement effects of baicalin on blood lipid metabolism and immune function in GDM rats. Conclusion Baicalin may improve blood lipid metabolism and immune function in GDM rats by inhibiting the RhoA/ROCK pathway.
